MDPI and ACS Style
Varaldo, E.; Rumbolo, F.; Prencipe, N.; Bioletto, F.; Settanni, F.; Mengozzi, G.; Grottoli, S.; Ghigo, E.; Brazzi, L.; Montrucchio, G.;
et al. Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission. J. Clin. Med. 2024, 13, 2019.
https://doi.org/10.3390/jcm13072019
AMA Style
Varaldo E, Rumbolo F, Prencipe N, Bioletto F, Settanni F, Mengozzi G, Grottoli S, Ghigo E, Brazzi L, Montrucchio G,
et al. Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission. Journal of Clinical Medicine. 2024; 13(7):2019.
https://doi.org/10.3390/jcm13072019
Chicago/Turabian Style
Varaldo, Emanuele, Francesca Rumbolo, Nunzia Prencipe, Fabio Bioletto, Fabio Settanni, Giulio Mengozzi, Silvia Grottoli, Ezio Ghigo, Luca Brazzi, Giorgia Montrucchio,
and et al. 2024. "Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission" Journal of Clinical Medicine 13, no. 7: 2019.
https://doi.org/10.3390/jcm13072019
